Gastrointestinal Oncology Program

Our GI Oncology Program delivers highly coordinated, expert care for every type of gastrointestinal cancer. Each patient’s case is reviewed by a multidisciplinary team of nationally recognized specialists in surgery, medical oncology, radiation oncology, gastroenterology, radiology, and pathology—many of whom are high-volume clinicians with extensive experience caring for complex and rare GI cancers. This collaborative approach ensures that every patient receives an individualized, evidence-based treatment plan.

We offer leading-edge diagnostic and therapeutic options, including advanced imaging, molecular and genomic profiling, robotic and minimally invasive surgery, organ-preserving endoscopic treatments, precision oncology, immunotherapy, and access to unique clinical trials developed by our own research teams. Patients can also benefit from rapid-access appointments for urgent symptoms, allowing faster evaluation and earlier initiation of care.

Care is delivered at the state-of-the-art Jack & Sheryl Morris Cancer Center, a comprehensive environment designed to bring all cancer services—clinical care, diagnostics, infusion, imaging, and supportive resources—together under one roof. Dedicated nurse navigators, nutritionists, social workers, genetic counselors, and supportive care specialists help guide patients and families at every step to ensure a seamless, compassionate experience from diagnosis through survivorship.

To request an appointment, call 844-CANCERNJ.

No, you do not necessarily need a referral to make an appointment with Rutgers Cancer Institute or RWJBarnabas Health providers at the Jack & Sheryl Morris Cancer Center. You can call the Access Center at 844-CANCERNJ (844-226-2376) and request a new patient appointment, or request a new appointment online.

Your insurance plan might require a referral form from your primary care physician or referring doctor for coverage. It is a good idea to check your benefits or contact your insurer.

Yes. Many patients seek second opinions from our team, especially for complex or rare gastrointestinal cancers. Our nationally recognized, high-volume specialists work together across surgery, medical oncology, radiation oncology, gastroenterology, pathology, and radiology to provide a thorough and unbiased review of your diagnosis and treatment options.

We also offer access to advanced diagnostics, minimally invasive and organ-preserving procedures, precision therapies, and unique clinical trials available only at the Jack & Sheryl Morris Cancer Center.

You can request a second-opinion appointment directly by calling 844-CANCERNJ (844-226-2376). No referral is required unless your insurance plan needs one.

Signs of gastrointestinal cancer can vary depending on the specific organ affected and stage of the disease. However, Common symptoms include persistent abdominal pain, unexplained weight loss or loss of appetite, changes in bowel habits, or blood in the stool. It's important to note that experiencing these symptoms does not necessarily mean you have cancer. If these symptoms persist, you should consult your healthcare provider for proper evaluation and diagnosis.

Yes, many forms of gastrointestinal cancer are treatable, especially when detected early. Treatment options may include surgery, chemotherapy, radiation therapy, targeted therapy, or immunotherapy, depending on the type and stage of cancer. Advances in medical technology, including cutting-edge clinical trials, continue to significantly improve outcomes for many cancer patients.

Screening recommendations vary depending on the type of gastrointestinal cancer. Colonoscopy is the most effective and widely recommended screening test for colorectal cancer. For other cancers—such as esophageal, stomach, pancreatic, and liver cancers—screening is generally offered to people at higher risk due to family history, certain medical conditions, precancerous changes, or genetic syndromes.

Our team reviews your personal risk factors to determine whether you may benefit from specialized screening or surveillance.